OMLONTI

omidenepag isopropyl · Ocuvex Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OMLONTI, covering 2022-09-22 to 2022-09-22. Get the full timeline:

Most recent: FDA Approved: OMLONTI — Original Application (Ocuvex Therapeutics, Inc.)